Already a Bloomberg.com user?
Sign in with the same account.
Posting strong growth thanks to hot products such as the anemia drug Aranesp
A small biotech player with a big presence in the HIV market with the drug Viread
Set to generate strong earnings growth thanks to savings from Pharmacia acquisition
A midsize German company with some promising products in the pipeline
Expected to weather new competition for its popular test for congestive heart failure
**Based on estimated 2003 earnings
Data: Bloomberg Financial Markets, BusinessWeek